Thank you for subscribing to CAS life sciences updates
You can look forward to monthly emails where we share the latest drug development and life sciences articles on CAS Insights™, our thought leadership blog, as well as behind-the-scenes information about new content in the CAS Content CollectionTM and capabilities in CAS solutions.
CAS is proud to be part of your drug development innovation journey.
Learn how you can benefit from our life sciences content in your current CAS solutions.
Latest from CAS Insights™
創薬
AI in drug discovery: Moving from potential to practical
CAS hosted Life Sciences Summits across three regions in 2025, exploring practical AI integration in drug discovery. Learn about data governance, implementation barriers, and modality-specific challenges.
エマージング・サイエンス
Nipah virus explained: Risks, realities, and the hope from new research
New Nipah cases in India have renewed focus on a high‑fatality zoonotic threat shaped by complex spillover dynamics, severe neurological disease, and limited medical countermeasures. Meanwhile, global efforts in diagonistcs, therapeutics, and vaccines are accelerating.
バイオテクノロジー
がん免疫療法における革新：二重特異性T細胞エンゲージャー
二重特異性T細胞エンゲージャーは、製造がより簡単になり、安全性がさらに向上したことにより、免疫療法の重要な治療法となることが期待されています。